TWD 77.8
(0.0%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 1.16 Billion TWD | 39.12% |
2022 | 834.81 Million TWD | -1.19% |
2021 | 844.85 Million TWD | 8.15% |
2020 | 781.19 Million TWD | 23.4% |
2019 | 633.05 Million TWD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | 1.21 Billion TWD | 4.65% |
2024 Q2 | 1 Billion TWD | -17.45% |
2023 Q3 | 1.01 Billion TWD | 0.99% |
2023 FY | 1.16 Billion TWD | 39.12% |
2023 Q1 | 867.44 Million TWD | 3.91% |
2023 Q2 | 1 Billion TWD | 15.98% |
2023 Q4 | 1.16 Billion TWD | 14.3% |
2022 Q4 | 834.81 Million TWD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Bio Preventive Medicine Corp. | 264.65 Million TWD | -338.827% |
Genomics BioSci & Tech. Co.,Ltd. | 1.13 Billion TWD | -2.429% |
Advagene Biopharma Co., Ltd. | 147.93 Million TWD | -685.071% |
Taiwan Bio Therapeutics Co., Ltd | 941.76 Million TWD | -23.321% |
NaviFUS Corp. | 490.53 Million TWD | -136.759% |
G&E Herbal Biotechnology Co., Ltd. | 883.09 Million TWD | -31.513% |
TaiRx, Inc. | 833.74 Million TWD | -39.297% |
Sinew Pharma Inc. | 1.36 Billion TWD | 14.815% |
Lin BioScience, Inc. | 3.59 Billion TWD | 67.71% |
TaiwanJ Pharmaceuticals Co., Ltd. | 73.55 Million TWD | -1478.872% |
Lumosa Therapeutics Co., Ltd. | 1.65 Billion TWD | 29.88% |
Anti-Microbial Savior BioteQ Co., Ltd | 128.04 Million TWD | -807.001% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 2.9 Billion TWD | 59.964% |
AP Biosciences Inc | 890.75 Million TWD | -30.382% |
Sunmax Biotechnology Co., Ltd. | 2.15 Billion TWD | 46.208% |
RBC Bioscience Corporation | 753.79 Million TWD | -54.073% |
Syngen Biotech Co.,Ltd. | 3.1 Billion TWD | 62.611% |
EirGenix Inc. | 11.16 Billion TWD | 89.596% |
Enimmune corporation | 604.82 Million TWD | -92.02% |
Lukas Biomedical Inc. | 441.19 Million TWD | -163.239% |
BRIM Biotechnology, Inc. | 1.77 Billion TWD | 34.705% |
3D Global Biotech Inc. | 324.14 Million TWD | -258.289% |
TaiMed Biologics Inc. | 3.89 Billion TWD | 70.174% |
Mycenax Biotech Inc. | 3.77 Billion TWD | 69.197% |
TCI GENE Inc. | 1.16 Billion TWD | 0.391% |
SynCore Biotechnology Co.,Ltd | 378.36 Million TWD | -206.951% |
Oneness Biotech Co., Ltd. | 15.36 Billion TWD | 92.441% |
Eusol Biotech Co.,Ltd. | 410.25 Million TWD | -183.087% |
Feng Chi Biotech Corp. | 301.03 Million TWD | -285.802% |
NeoCore Technology Co., Ltd. | 548.74 Million TWD | -111.643% |
TWi Biotechnology, Inc. | 396.85 Million TWD | -192.651% |
Neith Corporation | 192.15 Million TWD | -504.407% |
Sunny Pharmtech Inc. | 1.71 Billion TWD | 32.176% |
VBI | 452.1 Million TWD | -156.886% |
Ever Supreme Bio Technology Co., Ltd | 2.07 Billion TWD | 44.054% |
GeneReach Biotechnology Corp. | 1.17 Billion TWD | 1.255% |
Shine-On BioMedical Co.,Ltd. | 1.15 Billion TWD | -0.144% |
CHO Pharma, Inc. | 3.08 Billion TWD | 62.366% |
Andros Pharmaceuticals Co.,Ltd | 529.14 Million TWD | -119.483% |
MegaPro Biomedical Co., Ltd | 294.58 Million TWD | -294.25% |
Visgeneer Inc. | 397.17 Million TWD | -192.411% |
BioLASCO Taiwan Co., Ltd. | 573.13 Million TWD | -102.636% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 1.22 Billion TWD | 5.248% |
Sagittarius Life Science Corp | 664.72 Million TWD | -74.717% |
BioGend Therapeutics Co., Ltd. | 1.05 Billion TWD | -10.558% |
GlycoNex Incorporation | 1.55 Billion TWD | 25.208% |
Medigen Biotechnology Corp. | 8.52 Billion TWD | 86.38% |
Pharmosa Biopharm Inc. | 1.33 Billion TWD | 12.916% |
PharmaEngine, Inc. | 3.95 Billion TWD | 70.627% |
Intech Biopharm Corporation | 2.71 Billion TWD | 57.161% |
Taiwan Advance Bio-Pharmaceutical Inc. | 748.57 Million TWD | -55.147% |
BiOptic Inc. | 613.77 Million TWD | -89.221% |
TaiGen Biopharmaceuticals Holdings Limited | 1.22 Billion TWD | 5.566% |
Senhwa Biosciences, Inc. | 1.36 Billion TWD | 14.813% |
NatureWise Biotech & Medicals Corporation | 698.45 Million TWD | -66.28% |
OBI Pharma, Inc. | 5.6 Billion TWD | 79.275% |
Savior Lifetec Corporation | 3.82 Billion TWD | 69.618% |
Great Novel Therapeutics Biotech & Medicals | 644.84 Million TWD | -80.102% |
Level Biotechnology Inc. | 822.67 Million TWD | -41.172% |
Medigen Vaccine Biologics Corporation | 6.09 Billion TWD | 80.938% |
Meribank Biotech Co., Ltd | 1.06 Billion TWD | -9.358% |
Acepodia, Inc. | 6.81 Billion TWD | 82.967% |
Caliway Biopharmaceuticals Co., Ltd. | 3.82 Billion TWD | 69.649% |